BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 30718249)

  • 21. ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection.
    Zhou Y; Liao M; Zhu C; Hu Y; Tong T; Peng X; Li M; Feng M; Cheng L; Ren B; Zhou X
    Int J Oral Sci; 2018 Mar; 10(2):9. PubMed ID: 29555898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.
    Kobayashi-Sakamoto M; Tamai R; Isogai E; Kiyoura Y
    Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
    Kong EF; Kucharíková S; Van Dijck P; Peters BM; Shirtliff ME; Jabra-Rizk MA
    Infect Immun; 2015 Feb; 83(2):604-13. PubMed ID: 25422264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis.
    Park H; Myers CL; Sheppard DC; Phan QT; Sanchez AA; E Edwards J; Filler SG
    Cell Microbiol; 2005 Apr; 7(4):499-510. PubMed ID: 15760450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection.
    Bertolini M; Ranjan A; Thompson A; Diaz PI; Sobue T; Maas K; Dongari-Bagtzoglou A
    PLoS Pathog; 2019 Apr; 15(4):e1007717. PubMed ID: 31009520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
    Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
    Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis.
    Zhu C; Liao B; Ye X; Zhou Y; Chen X; Liao M; Cheng L; Zhou X; Ren B
    Int J Antimicrob Agents; 2021 Sep; 58(3):106394. PubMed ID: 34197906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.
    Fidel PL
    Adv Dent Res; 2006 Apr; 19(1):80-4. PubMed ID: 16672555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida albicans
    Naseem S; Douglas LM; Konopka JB
    mBio; 2019 Nov; 10(6):. PubMed ID: 31719181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerin+ DCs regulate innate IL-17 production in the oral mucosa during Candida albicans-mediated infection.
    Sparber F; Dolowschiak T; Mertens S; Lauener L; Clausen BE; Joller N; Stoitzner P; Tussiwand R; LeibundGut-Landmann S
    PLoS Pathog; 2018 May; 14(5):e1007069. PubMed ID: 29782555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fluconazole on the growth and adhesion of Candida albicans in the presence of antineoplastic agents.
    Fekete-Forgács K; Kis B; Nagy G; Lenkey B
    J Basic Microbiol; 1999; 39(5-6):305-10. PubMed ID: 10629971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
    In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasis.
    Kamai Y; Kubota M; Kamai Y; Hosokawa T; Fukuoka T; Filler SG
    Infect Immun; 2002 Sep; 70(9):5256-8. PubMed ID: 12183577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis.
    Kumar R; Saraswat D; Tati S; Edgerton M
    Infect Immun; 2015 Jul; 83(7):2614-26. PubMed ID: 25870228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.
    Huppler AR; Conti HR; Hernández-Santos N; Darville T; Biswas PS; Gaffen SL
    J Immunol; 2014 Feb; 192(4):1745-52. PubMed ID: 24442441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms.
    Seleem D; Benso B; Noguti J; Pardi V; Murata RM
    PLoS One; 2016; 11(6):e0157188. PubMed ID: 27284694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
    Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
    J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers.
    Lyon JP; de Resende MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):632-8. PubMed ID: 17052640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.